Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiple myeloma with t(11;14): impact of novel agents on outcome.
Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Rey-Bua B, Padilla I, García-Sanz R, Puig N, Gutiérrez NC, Mateos MV. Puertas B, et al. Blood Cancer J. 2023 Mar 20;13(1):40. doi: 10.1038/s41408-023-00807-9. Blood Cancer J. 2023. PMID: 36935422 Free PMC article.
Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma.
Puertas B, González-Calle V, Sobejano-Fuertes E, Escalante F, Queizán JA, Bárez A, Labrador J, Alonso-Alonso JM, García de Coca A, Cantalapiedra A, Villaescusa T, Aguilar-Franco C, Alejo-Alonso E, Rey-Bua B, López-Corral L, García-Sanz R, Puig N, Gutiérrez NC, Mateos MV. Puertas B, et al. Cancers (Basel). 2023 Mar 2;15(5):1558. doi: 10.3390/cancers15051558. Cancers (Basel). 2023. PMID: 36900349 Free PMC article.
Randomized phase II study of weekly carfilzomib 70 mg/m2 and dexamethasone with or without cyclophosphamide in relapsed and/or refractory multiple myeloma patients.
Puertas B, González-Calle V, Sureda A, Moreno MJ, Oriol A, González E, Rosiñol L, López J, Escalante F, Martínez-Lopez J, Carrillo E, Clavero E, Ríos-Tamayo R, Rey-Bua B, González-Rodríguez AP, Dourdil V, De Arriba F, González S, Pérez-de-Oteyza J, Hernández MT, García-Mateo A, Bargay J, Bladé J, Lahuerta JJ, San Miguel JF, Ocio EM, Mateos MV. Puertas B, et al. Haematologica. 2023 Oct 1;108(10):2753-2763. doi: 10.3324/haematol.2022.282490. Haematologica. 2023. PMID: 37102598 Free PMC article. Clinical Trial.
Monoclonal gammopathy of uncertain significance.
Alejo E, Puertas B, Mateos MV. Alejo E, et al. Among authors: puertas b. Med Clin (Barc). 2023 Sep 8;161(5):217-224. doi: 10.1016/j.medcli.2023.05.006. Epub 2023 Jun 15. Med Clin (Barc). 2023. PMID: 37330390 Review. English, Spanish.
A research center's experience of T-cell-redirecting therapies in triple-class refractory multiple myeloma.
Puertas B, Fernández-Sánchez A, Alejo E, Rey-Búa B, Martín-López AA, Pérez-López E, López-Parra M, López-Corral L, Gutiérrez-Gutiérrez NC, García-Sanz R, Puig N, González-Calle V, Mateos MV. Puertas B, et al. Blood Adv. 2024 Jul 9;8(13):3478-3487. doi: 10.1182/bloodadvances.2024012773. Blood Adv. 2024. PMID: 38717869 Free PMC article.
Variation in Susceptibility to Downy Mildew Infection in Spanish Minority Vine Varieties.
Boso S, Gago P, Santiago JL, Muñoz-Organero G, Cabello F, Puertas B, Puig A, Domingo C, Valdés ME, Moreno D, Diaz-Losada E, Cibriain JF, Dañobeitia-Artabe O, Rubio-Cano JA, Martínez-Gascueña J, Mena-Morales A, Chirivella C, Usón JJ, Martínez MC. Boso S, et al. Among authors: puertas b. Plants (Basel). 2023 Jul 13;12(14):2638. doi: 10.3390/plants12142638. Plants (Basel). 2023. PMID: 37514253 Free PMC article.
Holistic understanding of the response of grapevines to foliar application of seaweed extracts.
Zarraonaindia I, Cretazzo E, Mena-Petite A, Díez-Navajas AM, Pérez-López U, Lacuesta M, Pérez-Álvarez EP, Puertas B, Fernandez-Diaz C, Bertazzon N, Cantos-Villar E. Zarraonaindia I, et al. Among authors: puertas b. Front Plant Sci. 2023 Feb 24;14:1119854. doi: 10.3389/fpls.2023.1119854. eCollection 2023. Front Plant Sci. 2023. PMID: 36923130 Free PMC article.
30 results